[1] DI M,HUNTINGTON SF,OLSZEWSKI AJ.Challenges and opportunities in the management of diffuse large B-cell lymphoma in older patients[J].Oncologist,2021,26(2):120-132.
[2] SEGMAN Y,RIBAKOVSKY E,AVIGDOR A,et al.Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy:real-life experience[J].Leuk Lymphoma,2021,62(1):118-124.
[3] WANG J,XING Y,WANG Y,et al.A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer[J].J Exp Clin Cancer Res,2019,38(1):422-425.
[4] ZHANG X,TIAN T,SUN W,et al.Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer[J].Medicine,2017,96(26):e7346-7349.
[5] LI Y,TIAN Z,TAN Y,et al.Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer[J].Mol Cancer,2020,19(1):109-112.
[6] HU C,ZHANG Q,TANG Q,et al.CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer[J].J Cell Mol Med,2020,24(1):618-631.
[7] WANG L,LIU JL,YU L,et al.Downregulated miR-495 inhibits the G1-S phase transition by targeting Bmi-1 in breast cancer[J].Medicine,2015,94(1):7182015-7182019.
[8] MA DQ,ZHANG YH,DING DP,et al.Effect of Bmi-1-mediated NF-κB signaling pathway on the stem-like properties of CD133+ human liver cancer cells[J].Cancer Biomark,2018,22(3):575-585.
[9] YANG XX,MA M,SANG MX,et al.BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway[J].Oncol Rep,2018,39(2):667-678.
[10] ZACZEK A,JOZWIAK P,CIESIELSKI P,et al.Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer[J].J Cell Mol Med,2020,24(2):1300-1310.
[11] XU L,SUN HB,XU ZN,et al.MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1[J].Eur Rev Med Pharmacol Sci,2019,23(18):7978-7988.
[12] JAKOB M,SHARAF K,SCHIRMER M,et al.Role of cancer stem cell markers ALDH1,BCL11B,BMI-1,and CD44 in the prognosis of advanced HNSCC[J].Strahlenther Onkol,2021,197(3):231-245.
[13] XU Z,ZHOU Z,ZHANG J,et al.Targeting BMI-1-mediated epithelial-mesenchymal transition to inhibit colorectal cancer liver metastasis[J].Acta Pharm Sin B,2021,11(5):1274-1285.
[14] BEN YOUNES K,DOGHRI R,MRAD K,et al.PTEN loss and Cyclin A2 upregulation define a PI3K/AKT pathway activation in helicobacter pylori-induced MALT and DLBCL gastric lymphoma with features of MALT[J].Appl Immunohistochem Mol Morphol,2021,29(1):56-61.
[15] LI G,ZHANG C,LIANG W,et al.Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells[J].Pharm Biol,2021,59(1):21-30.
[16] JIANG M,HE G,LI J,et al.Hypoxic exposure activates the B cell-specific moloney murine leukaemia virus integration site 1/PI3K/Akt axis and promotes EMT in leukaemia stem cells[J].Oncol Lett,2021,21(2):98-101.